5 结果
Stroke in general is one of the leading causes for death and disability in the industrialized world. Cardiac thrombo-embolisms are the major contributor to ischemic infarction with atrial fibrillation [afib] being the most frequent underlying pathology. As the prevalence of afib is constantly
We propose to realize a single-center prospective registry of patient under Antithrombotic agent who came to the emergency unit for any reason.
Oral anticoagulants are effective in the treatment and prevention of venous and arterial thrombotic events. For more than 50 years the only class of anticoagulant available had been the vitamin K antagonist (VKA), warfarin, which requires frequent blood work for monitoring. Apixaban is a new
This is a pilot 2A trial of an innovative behavioral economics theory-based antidote for physician inertia in the medical treatment of hypertension (HTN). In the current reactive physician-centered model, blood pressure (BP) is measured and medical decisions are made in the physician office; when
Given the central role of thrombosis in the pathobiology of acute ischemic heart disease, injectable (intravenous or subcutaneous) anticoagulants have become the foundation of medical treatment for patients presenting with acute coronary syndromes (unstable angina and myocardial infarction; ACS) and